Skeletal muscle lipid metabolism with obesity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 4 47-4, 2003, Pages

  Hulver, Matthew W ^a   Berggren, Jason R ^a   Cortright, Ronald N ^a   Dudek, Ronald W ^a   Thompson, R Peter ^a   Pories, Walter J ^a   MacDonald, Kenneth G ^a   Cline, Gary W ^b   Shulman, Gerald I ^b   Dohm, G Lynis ^a   Houmard, Joseph A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acids; Intramyocellular triacylglycerol; Long chain fatty acyl coenzyme A

Indexed keywords

ACYL COENZYME A; LIPID; PALMITIC ACID;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID METABOLISM; MUSCLE METABOLISM; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0037376854     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00514.2002     Document Type: Article

References (40)

1. Barakat HA, Mooney N, O'Brien K, Long S, Khazani PG, Pories W, and Caro JF. Coronary heart disease risk factors in morbidly obese women with normal glucose tolerance. Diabetes Care 16: 144-149, 1993.
2. Bligh EG and Dryer WJ. A rapid method of total lipid extraction and purification. Can J Biochem 37: 911-917, 1959.
3. Chen KS, Heydrick S, Kurowski T, and Ruderman NB. Diacylglycerol-protein kinase C signalling in skeletal muscle: a possible link to insulin resistance. Trans Assoc Am Physicians 104: 206-212, 1991.
4. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002.
5. DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 50: 191-197, 1997.
6. Dohm GL, Elton CW, Raju MS, Mooney ND, DiMarchi R, Pories WJ, Flickinger EG, Atkinson SM Jr, and Caro JF. IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes 39: 1028-1032, 1990.
7. Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, Fushiki T, Atkinson SM, Elton CW, and Caro JF. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82: 486-494, 1988.
8. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, and Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279: E554-E560, 2000.
9. Elton CW, Tapscott EB, Pories WJ, and Dohm GL. Effect of moderate obesity on glucose transport in human muscle. Horm Metab Res 26: 181-183, 1994.
10. Felber JP, Ferrannini E, Golay A, Meyer H, Theibauld B, Curchod B, Maeder E, Jequier E, and DeFronzo R. Role of lipid oxidation in the pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-1350, 1987.
11. Flegal KM, Carroll MD, Kuczmarski RJ, and Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22: 39-47, 1998.
12. Flegal KM, Carroll MD, Ogden CL, and Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288: 1723-1727, 2002.
13. Forouhi NG, Jenkinson G, Thomas EL, Mullick S, Mierisova S, Bhonsle U, McKeigue PM, and Bell JD. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42: 932-935, 1999.
14. Goodpaster BH, Theriault R, Watkins SC, and Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49: 467-472, 2000.
15. Grigsby RJ and Dobrowsky RT. Inhibition of ceramide production reverses TNF-induced insulin resistance. Biochem Biophys Res Commun 287: 1121-1124, 2001.
16. Guesbeck NR, Hickey MS, MacDonald KG, Pories WJ, Harper I, Ravussin E, Dohm GL, and Houmard JA. Substrate utilization during exercise in formerly morbidly obese women. J Appl Physiol 90: 1007-1012, 2001.
17. Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, Downes CP, and Hundal HS. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44: 173-183, 2001.
18. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, and Dohm GL. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol Endocrinol Metab 268: E453-E457, 1995.
19. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, and Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119, 1999.
20. Kelley DE and Goodpaster BH. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24: 933-941, 2001.
21. Kelley DE, Goodpaster BH, Wing RR, and Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
22. Kim JY, Hickner RC, Cortright RL, Dohm GL, and Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000.
23. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, and Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
24. Kuczmarski RJ, Flegal KM, Campbell SM, and Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272: 205-211, 1994.
25. Montell E, Turini M, Marotta M, Roberts M, Noe V, Ciudad CJ, Mace K, and Gomez-Foix AM. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280: E229-E237, 2001.
26. National Institutes of Health: National Heart, Blood, and Lung Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health, 1998, p. xiv.
27. Neschen S, Moore I, Regittnig W, Yu CL, Wang Y, Pypaert M, Petersen KF, and Shulman GI. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab 282: E395-E401, 2002.
28. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
29. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600-1606, 1999.
30. Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, and Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-950, 1996.
31. Shmueli E, Alberti KG, and Record CO. Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? J Intern Med 234: 397-400, 1993.
32. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
33. Steinberg GR and Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab 279: E1374-E1382, 2000.
34. Steinberg GR, Parolin ML, Heigenhauser GJ, and Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192, 2002.
35. Tataranni PA, Larson DE, and Ravussin E. Body fat distribution and energy metabolism in obese men and women. J Am Coll Nutr 13: 569-574, 1994.
36. Teruel T, Hernandez R, and Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50: 2563-2571, 2001.
37. Thompson AL and Cooney GJ. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 49: 1761-1765, 2000.
38. Weyer C, Snitker S, Rising R, Bogardus C, and Ravussin E. Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord 23: 715-722, 1999.
39. Yu C, Chen Y, Zong H, Wang Y, Bergeron R, Kim JK, Cline GW, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
40. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Bogardus C, and Ravussin E. Low ratio of fat to carbohydrate oxidation as a predictor of weight gain: study of 24-h RQ. Am J Physiol Endocrinol Metab 259: E650-E657, 1990.